Clinical Site

Philadelphia, Pennsylvania 19107

0 studies enrolling now · 9 studies all time

What they study most

Acne Inversa, Bipolar Depression, C3 Glomerulopathy (C3G), Cardiovascular Disease, Celiac Disease, Elevated Lipoprotein(a), Hidradenitis Suppurativa, Respiratory Syncytial Virus Infections, Schizophrenia

Studies at this site

• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression — Completed
• PRV-015 in Gluten-free Diet Non-responsive Celiac Disease — Completed
• Study of a Novel Antipsychotic ITI-007 in Schizophrenia — Completed
• Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) — Completed
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed
• Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa — Completed
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression — Completed
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease — Completed
• Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed